Following characterization of AhR activation by leflunomide in mouse and human hepatoma cells, we evaluated the functional consequences of AhR activation in vivo using the embryonic zebrafish model.[9] We first evaluated whether leflunomide exposure induced AhR target gene CYP1A in vivo. The gene discussed is AHR; the disease is hepatocellular carcinoma.